XVI SO 2022

PROMOTER METHYLATION IS ASSOCIATED WITH miR-34b REDUCED EXPRESSION AND ITS RESTORATION DO NOT REVERSE CYTARABINE RESISTANCE PHENOTYPE IN AML, IN VITRO

XVI SO 2022

STUDY OF RELATION BETWEEN MIR-210 AND p53 IN CANCER

XVI SO 2022

TOB2 INDUCES CELL GROWTH AND CELL DEATH INHIBITION IN CANCER CELLS AND PRESENT A POTENTIAL BIOMARKER VALUE IN DIFFERENT TUMORS

XV SO 2021

miR-210 INHIBITION IN ASSOCIATION WITH IONIZING RADIATION REDUCES CELL VIABILITY IN GLIOBLASTOMA CELL LINE WITH WILD-TYPE TP53

XV SO 2021

STUDY OF INFLUENCE OF MICRORNA-34B IN ACUTE MYELOID LEUKEMIA RESPONSE TO CHEMOTHERAPY